To test this in humans, we analyzed B cells from a cohort of patients with Autoimmune Proliferative Syndrome (ALPS (17);) carrying FAS inactivating mutations (Supplementary Table S2). Here, FAS is linked to autoimmune lymphoproliferative syndrome.